Purchase Order 75N98C24P00037

Award Date 7/12/24
Potential Completion Date 8/30/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
North Potomac, MD 20878, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award to Biohippo Inc. has an award value of $13,000.00 and was issued by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency under the National Institutes of Health. The contract is for the delivery of FOLR2-CRE-2A-TDTOMATO mice, which are specialized biomedical research animal models. The contract does not have a set-aside designation. Biohippo Inc. is a self-certified small disadvantaged business that has previously provided...
This federal contract award, valued at $5,500.00, was issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency under the National Institutes of Health (NIH), to Biohippo Inc., a self-certified small disadvantaged business. The award is for the provision of PLVAP1-CRE-ER mice, a specialized animal model, to support research on vascular fenestrations in the central nervous system. The contract is a firm-fixed-price purchase order with a completion date of...
The National Institute on Aging, a civilian agency within the National Institutes of Health (NIH), awarded a firm-fixed price purchase order contract to Biohippo Inc., a self-certified small disadvantaged business, for the construction of a custom conditional knockout mouse. The contract has a ceiling value of $24,500.00 and a period of performance ending on November 20, 2024. Biohippo Inc. has a history of providing biomedical research services and equipment to various NIH institutes, including...
This firm-fixed-price purchase order was awarded by the National Institute on Alcohol Abuse and Alcoholism, a civilian agency within the U.S. Department of Health and Human Services, to Biohippo Inc. for an animal strain license in the amount of $12,000.00. Biohippo Inc. is a self-certified small disadvantaged business that specializes in providing biomedical research services and equipment to various institutes within the National Institutes of Health. This award did not have a set-aside...
This is a firm-fixed price purchase order award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the National Institutes of Health (NIH), to Biohippo Inc., a self-certified small disadvantaged business. The $15,000.00 contract is for animal model construction services to support NIAAA's biomedical research initiatives. Biohippo Inc. has a history of providing specialized laboratory equipment and gene-related services to various NIH institutes. This...
The National Institutes of Health (NIH) awarded a $14,565 firm-fixed price purchase order contract to Biohippo Inc., a self-certified small disadvantaged business, to provide services to generate conditional knockout mouse models using CRISPR/Cas9 technology. This contract was awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency, and has a completion date of April 30, 2023. Biohippo Inc. is an experienced provider of specialized laboratory equipment,...
This firm-fixed price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to Biohippo Inc., a self-certified small disadvantaged business. The $14,900.00 contract is for the provision of SENSAPEX MANIPULATORS, which are specialized laboratory equipment used to support biomedical research. Biohippo Inc. is a key supplier of various goods and services to multiple institutes...
Biohippo Inc. has been awarded a firm-fixed price purchase order valued at two thousand seven hundred seventy-four dollars and forty cents ($2,774.40) from the National Institutes of Health's National Institute of Neurological Disorders and Stroke to conduct construction, detection, and quality control reporting of the CBLN1 gene, identified as item number 12404. The work is to be completed by June 30, 2024 at the agency's location in Potomac, Maryland. As a self-certified small disadvantaged...
The National Institute on Aging (NIA), on behalf of the National Institute on Drug Abuse (NIDA), awarded a $25,098.00 firm fixed-price purchase order to Ingenious Targeting Laboratory Inc., a minority-owned, small disadvantaged business, for a Custom Conditional Gpnmb cDNA cassette Knockin mouse model. The purpose is to generate a Cre-inducible Gpnmb-diphtheria toxin receptor (DTR) knock-in mouse to study the role of GPNMB+ macrophages in skeletal muscle injury response and aging. The period...
This is a $19,680.00 firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services. The contract was awarded to Data Sciences International Inc. (DSI), a small disadvantaged business that specializes in providing telemetry, respiratory, and software solutions for preclinical physiologic monitoring to support biomedical research. The contract is for a "Mouse Blood...

This is a firm-fixed price purchase order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency within the National Institutes of Health (NIH), to Biohippo Inc., a self-certified small disadvantaged business. The $13,000.00 contract is for Biohippo Inc. to provide the C57BL/6SMOC-ESR2EM1(IRES-CREERT2)SMOC mouse line for use in NIDCD research protocol 1626. The award does not have a set-aside designation. Biohippo Inc. is the prime contractor and will be directly fulfilling the research equipment needs of NIDCD. This contract contributes to the agency's biomedical research efforts aimed at understanding and addressing communication disorders.

Generated 8/6/24, 11:08 AM